Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
Feil K, Adrion C, Teufel J, Bösch S, Claassen J, Giordano I, Hengel H, Jacobi H, Klockgether T, Klopstock T, Nachbauer W, Schöls L, Stendel C, Uslar E, van de Warrenburg B, Berger I, Naumann I, Bayer O, Müller HH, Mansmann U, Strupp M.
Feil K, et al. Among authors: bosch s.
BMC Neurol. 2017 Jan 10;17(1):7. doi: 10.1186/s12883-016-0786-x.
BMC Neurol. 2017.
PMID: 28068987
Free PMC article.
Clinical Trial.